HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88.

Abstract
The period of prevalence, 1988 inclusive, of Allergic Bronchopulmonary Aspergillosis (ABPA) and Allergic Bronchopulmonary Candiasis (ABPC), the two most frequently reported forms of allergic Bronchopulmonary Mycosis (ABPM), was investigated in an Irish regional hospital respiratory medicine outpatients, catchment area population 536,000. ABPM was defined by the presence of a majority of seven criteria: asthma, eosinophilia, elevated IgE, antibodies to Aspergillus Fumigatus or Candida Albicans, immediate skin test reaction to either fungus, culture of either fungus in sputum, and otherwise unexplained transient or permanent lung field x-ray abnormalities. New referrals were investigated for ABPM if they had asthma and eosinophilia, or asthma and lung field x-ray abnormalities. Fourteen patients with ABPM were identified from a total of 1390 new referrals, a period prevalence of just over one per cent. It is concluded that (1) ABPM is a relatively common disorder in an Irish regional hospital respiratory medicine outpatient population and (2) ABPC constitutes a higher proportion of this disorder than previously considered.
AuthorsS C Donnelly, H McLaughlin, C P Bredin
JournalIrish journal of medical science (Ir J Med Sci) Vol. 160 Issue 9 Pg. 288-90 (Sep 1991) ISSN: 0021-1265 [Print] Ireland
PMID1769811 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aspergillosis, Allergic Bronchopulmonary (diagnosis, epidemiology)
  • Candidiasis (diagnosis, epidemiology)
  • Child
  • Female
  • Humans
  • Ireland
  • Lung Diseases, Fungal (diagnosis, epidemiology)
  • Male
  • Middle Aged
  • Outpatient Clinics, Hospital
  • Prevalence
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: